Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36237799)
Watch
English
What Is the Purpose of the Orphan Drug Act?
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
title
What Is the Purpose of the Orphan Drug Act?
(English)
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
main subject
orphan drug
1 reference
based on heuristic
inferred from title
author name string
Matthew Herder
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
language of work or name
English
0 references
publication date
3 January 2017
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
published in
PLOS MEDICINE
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
volume
14
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
issue
1
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
page(s)
e1002191
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
copyright license
Creative Commons Attribution 4.0 International
start time
3 January 2017
1 reference
stated in
April 2022 Public Data File from Crossref
copyright status
copyrighted
0 references
cites work
Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
1 October 2017
Orphan drug incentives in the pharmacogenomic context: policy responses in the US and Canada
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
1 October 2017
Funding innovation for treatment for rare diseases: adopting a cost-based yardstick approach.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
1 October 2017
Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
1 October 2017
Orphan drug development: an economically viable strategy for biopharma R&D.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
1 October 2017
An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
1 October 2017
Pricing and reimbursement of orphan drugs: the need for more transparency
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
1 October 2017
Pregnant women deserve better
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
1 October 2017
The US Orphan Drug Act: rare disease research stimulator or commercial opportunity?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
1 October 2017
Drugs for neglected diseases: a failure of the market and a public health failure?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
1 October 2017
Potential interactions of the Orphan Drug Act and pharmacogenomics: a flood of orphan drugs and abuses?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5207521
retrieved
22 September 2018
Pharmacogenetic interventions, orphan drugs, and distributive justice: the role of cost-benefit analysis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/28045908
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1371/JOURNAL.PMED.1002191
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
PMCID
5207521
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
PubMed ID
28045908
1 reference
stated in
Europe PubMed Central
PMCID
5207521
retrieved
12 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
